News Daily News New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists Yael L. Maxwell August 14, 2025
News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Daily News Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT Michael O'Riordan July 31, 2025
News Daily News PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors Michael O'Riordan July 18, 2025
News Daily News POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies L.A. McKeown July 15, 2025
News Daily News Baxdrostat Shows Promise in Uncontrolled or Resistant Hypertension L.A. McKeown July 14, 2025
News Daily News FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF Caitlin E. Cox July 14, 2025
News Daily News CV Risk Modest for Most Cancer Survivors in Large Danish Registry L.A. McKeown June 17, 2025
News Daily News Majority of US Adults Have High Long-term Risk of CVD: NHANES Michael O'Riordan June 13, 2025
News Daily News PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a) Michael O'Riordan June 10, 2025
News Daily News Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry Caitlin E. Cox June 09, 2025
News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding L.A. McKeown May 16, 2025
News Daily News AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease Caitlin E. Cox May 06, 2025
News Daily News Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN Yael L. Maxwell April 29, 2025
News Daily News Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds Michael O'Riordan April 25, 2025
News Daily News High-Sensitivity Troponin Tests Might Aid in Primary Prevention Yael L. Maxwell April 16, 2025
News Daily News Sotagliflozin Reduces Ischemic Risk in SCORED Analysis Yael L. Maxwell February 25, 2025
News Daily News Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study Yael L. Maxwell February 20, 2025